Serum uromodulin predicts less coronary artery calcification and diabetic kidney disease over 12 years in adults with type 1 diabetes: The CACTI Study
Diabetes Care Dec 02, 2018
Bjornstad P, et al. – Researchers evaluated the associations between serum uromodulin (SUMOD), coronary artery calcification (CAC) progression, and diabetic kidney disease (DKD) development over 12 years in this investigation. A total of 527 participants (53% females) in the Coronary Artery Calcification in Type 1 Diabetes (CACTI) study were examined in 2002–2004, at an average age of 39.6 ± 9.0 years and a median duration of diabetes of 24.8 years. In adults with type 1 diabetes, higher baseline SUMOD level predicted lower odds of both CAC progression and incident DKD over 12 years.
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries